NCT04239300 is a NA clinical trial of Delivery in water in Water Birth, sponsored by Akusherstvo Pro.

Who is sponsoring NCT04239300?

NCT04239300 is sponsored by Akusherstvo Pro.

What drugs are being tested in NCT04239300?

Interventions in NCT04239300: Delivery in water.

What condition does NCT04239300 study?

NCT04239300 studies Water Birth.

Is NCT04239300 still recruiting?

NCT04239300 is currently completed. Last updated 21 May 2021.

Last reviewed 2021-05-21 · How we verify

NCT04239300

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficiency and Safety of Water Birth

Completed NA Last updated 21 May 2021

What this trial tests

NA trial testing Delivery in water in Water Birth in 1,080 participants. Completed in 27 April 2021.

Timeline

11 March 2020

Primary endpoint
27 April 2021

27 April 2021

Quick facts

Lead sponsor	Akusherstvo Pro
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	1,080
Start date	11 March 2020
Primary completion	27 April 2021
Estimated completion	27 April 2021
Sites	2 locations across Russia

Drugs / interventions tested

Delivery in water

Conditions studied

Water Birth — all drugs for Water Birth →

Sponsor

Akusherstvo Pro

Who can join

Adults 18 to 45, female only, with Water Birth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Water birth are not risks factors for newborns.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Water Birth

Currently open trials in the same condition.

NCT06441370 — Patient Satisfaction During Physiological Water or Land Birth: a Prospective Study in an French Tertiary Maternity Unit. · recruiting

Other Akusherstvo Pro trials

Trials by the same sponsor.

NCT04218877 — The Factors Affecting Atopic Dermatitis in Children Age 1-3 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04239300 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Akusherstvo Pro
Last refreshed: 21 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04239300.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing